TRIM16 and cancer: AKT signaling, known to be active in cancer cells (52), has been shown to mediate lncRNA VAL binding to Vimentin to eliminate Trim16-dependent Vimentin polyubiquitination and degradation and promote LAD invasion and metastasis (32).